NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.25% | 6.14% | 4.61% | 1.70% | -0.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.25% | 6.14% | 4.61% | 1.70% | -0.44% |
| Cost of Revenue | 6.12% | 4.44% | 3.05% | 0.06% | -1.49% |
| Gross Profit | 12.33% | 14.06% | 11.98% | 9.55% | 4.58% |
| SG&A Expenses | 8.53% | 6.22% | 1.70% | -5.36% | -13.73% |
| Depreciation & Amortization | -4.24% | -2.95% | -2.47% | -5.95% | -15.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.05% | 4.39% | 2.63% | -0.99% | -3.97% |
| Operating Income | 247.61% | 801.24% | 203.36% | 133.70% | 115.58% |
| Income Before Tax | 62.97% | 108.36% | 98.44% | 101.48% | 60.01% |
| Income Tax Expenses | -44.42% | 20.12% | 24.22% | 21.26% | 298.79% |
| Earnings from Continuing Operations | 59.75% | 100.18% | 91.62% | 95.77% | 49.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -239.53% | -147.52% | -89.40% | -37.31% | 36.77% |
| Net Income | 44.94% | 97.59% | 91.72% | 97.63% | 52.01% |
| EBIT | 247.61% | 801.24% | 203.36% | 133.70% | 115.58% |
| EBITDA | 26.46% | 49.80% | 71.58% | 147.13% | 432.58% |
| EPS Basic | 51.93% | 97.77% | 92.62% | 97.66% | 53.31% |
| Normalized Basic EPS | 63.33% | 86.36% | 77.06% | 85.03% | 89.01% |
| EPS Diluted | 32.62% | 92.41% | 87.96% | 97.66% | 53.31% |
| Normalized Diluted EPS | 63.33% | 85.48% | 76.19% | 84.70% | 88.85% |
| Average Basic Shares Outstanding | 5.05% | 8.07% | 12.53% | 13.70% | 12.81% |
| Average Diluted Shares Outstanding | 5.11% | 6.02% | 10.40% | 11.51% | 10.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
